Sigma Aldrich launches services network for life sciences industry
17 July 2009
Sigma-Aldrich (NASDAQ: SIAL) has launched a Services Network designed
to provide laboratory services for the pharmaceutical and biotechnology
industry. The new Services Network provides researchers with convenient
access to a wide variety of laboratory-based services from a centralized
The Network will allow scientists to engage Sigma-Aldrich resources
and certified partners for laboratory services on an as-needed basis,
freeing them to concentrate on core research objectives.
With this new Services Network, scientists from the pharmaceutical
and biotechnology industry can select from a menu of laboratory
services, including cloning, mass spectrometry based protein
characterization, protein expression and protein purification services
to supplement their research and support drug discovery.
The Services Network includes Sigma-Aldrich’s core capabilities and
numerous Sigma Certified partners located in the United States as well
as from emergent locales. Additional certified partners are expected to
be added in the future, expanding the services menu.
“The Sigma-Aldrich Services Network offers a powerful tool that
addresses an expanding demand for services to support advanced life
science research. While many companies may offer individual services,
our global network offers an expanding variety of services, complements
our product portfolio and comes with the single-source convenience and
the proven reliability of Sigma-Aldrich,” said Helge Bastian, Vice
President of Marketing and Business Development at Sigma-Aldrich.
Bookmark this page